[EN] AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES<br/>[FR] INHIBITEURS AMINOTHIAZOLES DE KINASES DEPENDANTES DE LA CYCLINE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2001044217A1
公开(公告)日:2001-06-21
Compounds of formula (I) and pharmaceutically acceptable salts thereof. As used in formula (I), and throughout the specification, the symbols have the following meanings: R1 and R2 are independently hydrogen, fluorine or alkyl; R3 is aryl or heteroaryl, R4 has various meanings; R5 is hydrogen or alkyl; m is an integer of 0 to 2; and n is an integer of 1 to 3. The compounds of formula (I) are protein kinase inhibitors and are useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of neurodegenerative diseases such as Alzheimer's diseases cardiovascular diseases, viral diseases and fungal diseases.